Sanofi-Aventis Keeps Optimedia

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

French pharmaceutical giant Sanofi-Aventis has opted to retain Publicis Groupe’s Optimedia for global media chores after a review, according to sources.

Estimated worldwide spending on the account is $450 million.

In the U.S., the company spent $210 million in measured media, excluding digital, in 2009, down 15 percent from $245 million in ’08, according to Nielsen.

Through the first seven months of this year, the client spent $90 million on domestic ads, per Nielsen.

Other contenders were not immediately known, although the client is believed to have contacted the major holding companies during the process.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in